Diaceutics (DXRX) Stock Chart & Stock Price History GBX 121.10 -0.90 (-0.74%) As of 09:49 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock Diaceutics Stock Price Performance 5 Day Performance+2.19%1 Month Performance+2.63%3 Month Performance-11.12%6 Month Performance-0.33%Year-To-Date Performance-1.54%1 Year Performance+21.71% Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DXRX Stock Chart for Friday, May, 2, 2025 DXRX Chart by TradingView Diaceutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025GBX 120GBX 122+1.67%GBX 124GBX 12089,194 shs£102.96 million04/30/2025GBX 118GBX 120+1.69%GBX 121GBX 118114,436 shs£101.27 million04/29/2025GBX 116.50GBX 118+1.29%GBX 120GBX 11523,993 shs£99.59 million04/28/2025GBX 118.50GBX 116.50-1.69%GBX 120GBX 116.5021,303 shs£98.32 million04/25/2025GBX 118GBX 118.50+0.42%GBX 118.50GBX 117.1514,362 shs£100.01 million04/24/2025GBX 117.75GBX 118+0.21%GBX 122GBX 11750,206 shs£99.59 million04/23/2025GBX 117GBX 117.75+0.64%GBX 120GBX 116.2053,064 shs£99.37 million04/22/2025GBX 121GBX 117-3.31%GBX 122GBX 117103,295 shs£98.74 million04/21/2025GBX 121GBX 121GBX 121GBX 11532,265 shs£102.12 million04/18/2025GBX 121GBX 121GBX 121GBX 11532,265 shs£102.12 million Get the Latest News and Ratings for DXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025GBX 121GBX 121GBX 121GBX 11532,265 shs£102.12 million04/16/2025GBX 118GBX 121+2.54%GBX 122GBX 11678,478 shs£102.12 million04/15/2025GBX 113GBX 118+4.42%GBX 120GBX 11058,056 shs£99.59 million04/14/2025GBX 113.75GBX 113-0.66%GBX 115GBX 112.4029,799 shs£95.37 million04/11/2025GBX 110GBX 113.75+3.41%GBX 113.75GBX 11026,446 shs£96.00 million04/10/2025GBX 108GBX 110+1.85%GBX 115GBX 11077,110 shs£92.83 million04/09/2025GBX 110GBX 108-1.82%GBX 110GBX 10838,914 shs£91.15 million04/09/2025GBX 110GBX 108-1.82%GBX 110GBX 10838,914 shs£91.15 million04/08/2025GBX 107.84GBX 110+2.00%GBX 112GBX 108.5056,763 shs£92.83 million04/08/2025GBX 107.84GBX 110+2.00%GBX 112GBX 108.5056,763 shs£92.83 million04/07/2025GBX 111.05GBX 107.84-2.89%GBX 110GBX 107.84168,117 shs£91.01 million04/04/2025GBX 115GBX 111.05-3.44%GBX 116.75GBX 110122,514 shs£93.72 million04/03/2025GBX 118GBX 115-2.54%GBX 118GBX 115135,318 shs£97.05 million04/02/2025GBX 120GBX 118-1.67%GBX 122GBX 117.5029,167 shs£99.59 million04/01/2025GBX 122GBX 120-1.64%GBX 122.50GBX 12042,096 shs£101.27 million Related Companies ANGLE Stock Chart Abingdon Health Stock Chart genedrive Stock Chart Proteome Sciences Stock Chart Verici Dx Stock Chart GENinCode Stock Chart LungLife AI Stock Chart LLA.L,0P0001T9GN,0 Stock Chart Integrated Diagnostics Stock Chart PureTech Health Stock Chart Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DXRX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.